Author | Maki Tanioka, MD, PhD | OncLive

Author | Maki Tanioka, MD, PhD

Articles

Dr. Tanioka on the Results of CALGB 40601 in HER2+ Breast Cancer

March 08, 2017

Video

Maki Tanioka, MD, PhD, UNC Lineberger Comprehensive Cancer Center, discusses the results of the phase III CALGB 40601 (Alliance) study in HER2-positive breast cancer.

x